Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Current Deferred Revenue for 4 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 10.27% year-over-year to $2.9 billion, compared with a TTM value of $2.9 billion through Dec 2025, up 10.27%, and an annual FY2025 reading of $2.9 billion, up 10.27% over the prior year.
  • Current Deferred Revenue was $2.9 billion for Q4 2025 at GE HealthCare Technologies, up from $2.0 billion in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $2.9 billion in Q4 2025 and bottomed at $1.9 billion in Q2 2024.
  • Average Current Deferred Revenue over 4 years is $2.3 billion, with a median of $2.6 billion recorded in 2024.
  • The sharpest move saw Current Deferred Revenue decreased 29.82% in 2024, then skyrocketed 44.99% in 2025.
  • Year by year, Current Deferred Revenue stood at $1.9 billion in 2022, then skyrocketed by 38.34% to $2.6 billion in 2023, then increased by 0.23% to $2.6 billion in 2024, then rose by 10.27% to $2.9 billion in 2025.
  • Business Quant data shows Current Deferred Revenue for GEHC at $2.9 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.7 billion in Q2 2025.